"The initial payment will help cover substantially the costs of our upcoming clinical study of oral-dosed Brilacidin currently being developed for treating Ulcerative Colitis (UC). "

A normal Phase 2 costs are roughly $7m-$20m so the up front payment is not $1m like some suggest.